saxenda glp 1 agonist First Generic GLP-1 Injection OK'd for Weight Loss Generic Liraglutide Approved, Marking First
Description
178 All the above mechanisms suggest that diabetes-related metabolic factors may promote PD by regulating the mitochondria
The oral drug also had a safety profile consistent with its injectable formulation
The cardiovascular benefits of GLP-1-RAs arise primarily through indirect systemic mechanisms, with limited evidence supporting direct effects on cardiomyocytes ( Figure 1 )
Effects of Liraglutide on Weight Loss, Fat Distribution, and -Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes
J.PetrikD
.webp)
